A new trading day began on Monday, with Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) stock price down -3.26% from the previous day of trading, before settling in for the closing price of $21.18. ARWR’s price has ranged from $17.05 to $39.83 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 21.04%. Meanwhile, its annual earnings per share averaged -137.89%. With a float of $118.50 million, this company’s outstanding shares have now reached $124.31 million.
Let’s determine the extent of company efficiency that accounts for 525 employees. In terms of profitability, gross margin is 11.29%, operating margin of -2785.05%, and the pretax margin is -2792.41%.
Arrowhead Pharmaceuticals Inc. (ARWR) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Arrowhead Pharmaceuticals Inc. is 4.68%, while institutional ownership is 79.29%. The most recent insider transaction that took place on Jul 02 ’24, was worth 237,480. In this transaction Chief Commercial Officer of this company sold 9,394 shares at a rate of $25.28, taking the stock ownership to the 127,107 shares. Before that another transaction happened on May 02 ’24, when Company’s Director sold 1,799 for $23.31, making the entire transaction worth $41,935. This insider now owns 30,205 shares in total.
Arrowhead Pharmaceuticals Inc. (ARWR) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -1.02 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -137.89% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.33% during the next five years compared to -24.19% drop over the previous five years of trading.
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) Trading Performance Indicators
Here are Arrowhead Pharmaceuticals Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.65. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 129.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.65, a number that is poised to hit -0.97 in the next quarter and is forecasted to reach -4.36 in one year’s time.
Technical Analysis of Arrowhead Pharmaceuticals Inc. (ARWR)
Looking closely at Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR), its last 5-days average volume was 1.32 million, which is a jump from its year-to-date volume of 1.22 million. As of the previous 9 days, the stock’s Stochastic %D was 86.26%. Additionally, its Average True Range was 0.92.
During the past 100 days, Arrowhead Pharmaceuticals Inc.’s (ARWR) raw stochastic average was set at 25.75%, which indicates a significant decrease from 78.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.36% in the past 14 days, which was lower than the 50.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $21.29, while its 200-day Moving Average is $26.27. However, in the short run, Arrowhead Pharmaceuticals Inc.’s stock first resistance to watch stands at $21.17. Second resistance stands at $21.85. The third major resistance level sits at $22.53. If the price goes on to break the first support level at $19.81, it is likely to go to the next support level at $19.13. Now, if the price goes above the second support level, the third support stands at $18.45.
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) Key Stats
With a market capitalization of 2.55 billion, the company has a total of 124,200K Shares Outstanding. Currently, annual sales are 240,740 K while annual income is -205,280 K. The company’s previous quarter sales were 0 K while its latest quarter income was -125,300 K.
